Literature DB >> 6323814

[Diagnosis and surgery of an insulinoma using a glucose-controlled insulin infusion system].

G Müller-Esch, A Valesky, U Weber, G Wood.   

Abstract

A 71-year-old woman with insulinoma was studied. Preoperatively, using the glucose controlled insulin infusion system (GCIIS) for glucose clamping at various blood glucose levels, autonomous insulin production was demonstrated and intravenous glucose needs for maintenance of normoglycaemia were evaluated. The results of a somatostatin suppression test, guided by the GCIIS, supported the postulation of a well differentiated beta cell adenoma with reduced storage capacity. These assumptions were later confirmed by histochemical and ultrastructural investigations. Hypoglycaemia during surgery was avoided by means of the GCIIS. Upon clamping of the plasma glucose at 90 mg/dl, 15.5 g dextrose had to be given until resection of the tumour. Immediately thereafter, a sharp rise in plasma glucose to 140 mg/dl together with a need for 4.1 U insulin showed that the insulinoma tissue had been removed completely.

Entities:  

Mesh:

Year:  1984        PMID: 6323814     DOI: 10.1007/bf01769667

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  25 in total

1.  Prolonged suppression of insulin release by insulin-induced hypoglycemia: demonstration by C-peptide assay.

Authors:  D L Horwitz; A H Rubenstein; C Reynolds; G D Molnar; N Yanaihara
Journal:  Horm Metab Res       Date:  1975-11       Impact factor: 2.936

2.  Artificial beta-cell application in two cases of insulinoma: a different pattern in beta-cell adenoma and carcinoma.

Authors:  P Brunetti; F Santeusanio; A Puxeddu; M Massi-Benedetti; G Calabrese; G Angeletti; A Bueti; L Scionti; M De Angelis
Journal:  Horm Metab Res Suppl       Date:  1979

3.  [Clinical aspects, diagnosis and treatment of organic hyperinsulinism. Experience with 46 operated patients (author's transl)].

Authors:  F Spelsberg; R Landgraf; R Wirsching; G Heberer
Journal:  MMW Munch Med Wochenschr       Date:  1978-04-21

4.  Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.

Authors:  R C Turner; L G Heding
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

5.  Insulinoma resection facilitated by the artificial endocrine pancreas.

Authors:  J E Kudlow; A M Albisser; A Angel; B Langer; C C Yip; B Zinman; E Stokes
Journal:  Diabetes       Date:  1978-07       Impact factor: 9.461

6.  Feedback-controlled dextrose infusion during surgical management of insulinomas.

Authors:  J H Karam; M Lorenzi; C W Young; A D Burns; P R Prosser; G M Grodsky; M Galante; P H Forsham
Journal:  Am J Med       Date:  1979-04       Impact factor: 4.965

7.  Continuous monitoring of blood glucose during operation for islet cell adenomas.

Authors:  J H Landor; D M Klachko; T H Lie
Journal:  Ann Surg       Date:  1970-03       Impact factor: 12.969

8.  Inhibition of insulin secretion by somatostatin.

Authors:  K G Alberti; N J Christensen; S E Christensen; A P Hansen; J Iversen; K Lundbaek; K Seyer-Hansen; H Orskov
Journal:  Lancet       Date:  1973-12-08       Impact factor: 79.321

9.  Human insulinoma tissue: in vitro studies of proinsulin/insulin biosynthesis and release.

Authors:  N S Track; C Creutzfeldt; W Creutzfeldt
Journal:  Horm Metab Res       Date:  1976       Impact factor: 2.936

10.  Lack of suppression of insulin secretion by exercise in patients with insulinoma.

Authors:  J Järhult; M Ericsson; J Holst; S Ingemansson
Journal:  Clin Endocrinol (Oxf)       Date:  1981-10       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.